These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 1855226
41. p53 Mutations in human hepatocellular carcinomas from Germany. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M. Cancer Res; 1992 Jun 01; 52(11):3220-3. PubMed ID: 1317262 [Abstract] [Full Text] [Related]
42. p53 mutations in human lung tumors. Miller CW, Simon K, Aslo A, Kok K, Yokota J, Buys CH, Terada M, Koeffler HP. Cancer Res; 1992 Apr 01; 52(7):1695-8. PubMed ID: 1312896 [Abstract] [Full Text] [Related]
43. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR. Cancer Res; 1991 Aug 01; 51(15):4090-6. PubMed ID: 1855224 [Abstract] [Full Text] [Related]
44. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Jung M, Notario V, Dritschilo A. Cancer Res; 1992 Nov 15; 52(22):6390-3. PubMed ID: 1423286 [Abstract] [Full Text] [Related]
49. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Ohgaki H, Hard GC, Hirota N, Maekawa A, Takahashi M, Kleihues P. Cancer Res; 1992 May 15; 52(10):2995-8. PubMed ID: 1316233 [Abstract] [Full Text] [Related]
50. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI. Cancer Res; 1992 May 01; 52(9):2610-5. PubMed ID: 1568228 [Abstract] [Full Text] [Related]
51. p53 mutations in formaldehyde-induced nasal squamous cell carcinomas in rats. Recio L, Sisk S, Pluta L, Bermudez E, Gross EA, Chen Z, Morgan K, Walker C. Cancer Res; 1992 Nov 01; 52(21):6113-6. PubMed ID: 1394239 [Abstract] [Full Text] [Related]
53. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. Prior SL, Griffiths AP, Lewis PD. Br J Dermatol; 2009 Nov 01; 161(5):1067-71. PubMed ID: 19624548 [Abstract] [Full Text] [Related]
54. p53 mutations in breast cancer. Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. Cancer Res; 1992 Oct 01; 52(19):5291-8. PubMed ID: 1394133 [Abstract] [Full Text] [Related]
58. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T. J Gastroenterol Hepatol; 2000 Oct 01; 15(10):1151-7. PubMed ID: 11106095 [Abstract] [Full Text] [Related]
59. Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Tanaka H, Shibagaki I, Shimada Y, Wagata T, Imamura M, Ishizaki K. Int J Cancer; 1996 Jan 26; 65(3):372-6. PubMed ID: 8575860 [Abstract] [Full Text] [Related]
60. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N, Akiyama M. Cancer Res; 1992 Mar 01; 52(5):1369-71. PubMed ID: 1737400 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]